Feb 2021 1 Philogen announces its intention to float on the Mercato Telematico Azionario organised and managed by Borsa Italiana S.P.A
Jan 2021 13 Philogen announces the completion of a second interim analysis of its phase III clinical program with NidlegyTM for the treatment of melanoma
